Visual fields in young children treated with vigabatrin. 2009

Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
Department of Ophthalmology, Children's Hospital, Boston and Harvard Medical School, Boston, Massachusetts 02115, USA.

OBJECTIVE To evaluate white sphere kinetic perimetry (WSKP) as a test of the peripheral visual field in young children with a history of epilepsy and treatment with Vigabatrin (VGB). VGB is an antiepileptic medication that is associated with visual field constriction. METHODS Thirty-one VGB patients and 10 control subjects, median age 6 years, were recruited. Visual field extent on the major oblique meridia was tested with a 6 degrees white sphere and WSKP, a method used by Quinn et al. to study field extent in children with retinopathy of prematurity. The same meridia were tested using Goldmann kinetic perimetry (GKP; 1.7 degrees target) in those who were capable. Monocular and binocular tests were conducted. Visual field extent for WSKP and GKP were compared in VGB patients and control subjects. RESULTS Twenty-eight of 31 VGB patients were testable with binocular WSKP and their median visual field extents were smaller than controls. In 8 of 28 (29%) VGB patients, binocular field extents were smaller than the minimum in the control subjects. Monocular WSKP results did not differ between VGB patients and control subjects. Nine VGB patients were testable with both WSKP and GKP; visual field extents did not differ between tests. CONCLUSIONS WSKP is feasible in VGB patients, even in those with developmental delays. WSKP has the potential to detect visual field constriction associated with VGB use.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D005240 Feasibility Studies Studies to determine the advantages or disadvantages, practicability, or capability of accomplishing a projected plan, study, or project. Feasibility Study,Studies, Feasibility,Study, Feasibility
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D014794 Visual Fields The total area or space visible in a person's peripheral vision with the eye looking straightforward. Field, Visual,Fields, Visual,Visual Field
D058609 Visual Field Tests Method of measuring and mapping the scope of vision, from central to peripheral of each eye. Automated Perimetry Exam,Campimetry,Perimetry,Tangent Screen Exam,Visual Field Exam,Automated Perimetry Exams,Campimetries,Exam, Automated Perimetry,Exam, Tangent Screen,Exam, Visual Field,Exams, Automated Perimetry,Exams, Tangent Screen,Exams, Visual Field,Field Exam, Visual,Field Exams, Visual,Field Test, Visual,Field Tests, Visual,Perimetries,Perimetry Exam, Automated,Perimetry Exams, Automated,Screen Exam, Tangent,Screen Exams, Tangent,Tangent Screen Exams,Test, Visual Field,Tests, Visual Field,Visual Field Exams,Visual Field Test
D020888 Vigabatrin An analogue of GAMMA-AMINOBUTYRIC ACID. It is an irreversible inhibitor of 4-AMINOBUTYRATE TRANSAMINASE, the enzyme responsible for the catabolism of GAMMA-AMINOBUTYRIC ACID and is used as an anticonvulsant. (From Martindale The Extra Pharmacopoeia, 31st ed) gamma-Vinyl-gamma-Aminobutyric Acid,Sabril,Sabrilex,gamma-Vinyl-GABA,gamma Vinyl GABA,gamma Vinyl gamma Aminobutyric Acid

Related Publications

Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
February 2009, Epilepsia,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
May 1999, Neurology,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
July 2000, Annals of neurology,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
July 2010, Epilepsia,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
January 2000, Ugeskrift for laeger,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
January 2001, Ugeskrift for laeger,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
March 2003, Journal of neurology, neurosurgery, and psychiatry,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
November 1999, Ugeskrift for laeger,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
July 2002, Epilepsia,
Shivi Agrawal, and D Luisa Mayer, and Ronald M Hansen, and Anne B Fulton
July 1988, Behavioural brain research,
Copied contents to your clipboard!